Agoracom Blog Home

Posts Tagged ‘gut health’

Else Nutrition $BABY.ca Announces Closing of $20.7 Million Upsized Bought Deal Public Offering and Concurrent $5 million Private Placement $BMY $ABT $TSN $CAG

Posted by AGORACOM-JC at 10:07 AM on Tuesday, October 6th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Closed its previously announced upsized bought deal public offering of units for ‎aggregate gross proceeds of approximately CAD$20.7 million, including the exercise of the over-allotment option in full
  • The Company issued ‎‎9,200,000 Units at a price of CAD$2.25 per Unit, each Unit consisting of one common share of the ‎Company and one-half of one common share purchase warrant, with each whole warrant entitling the holder to purchase one Share at the price of CAD$3.25 per Share until October 6, 2022
  • In total, the Company received gross proceeds of approximately CAD$25.7 million from the closing of the Offering and Private Placement

VANCOUVER, BC / October 6, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), is pleased to announce that it has closed its previously announced upsized bought deal public offering of units (the “Units“) for ‎aggregate gross proceeds of approximately CAD$20.7 million, including the exercise of the over-allotment option in full (the “Offering“). The Company issued ‎‎9,200,000 Units at a price of CAD$2.25 per Unit, each Unit consisting of one common share of the ‎Company (a “Share“) and one-half of one common share purchase warrant, with each whole warrant (a “Warrant“) ‎entitling the holder to purchase one Share at the price of CAD$3.25 per Share until October 6, 2022. ‎The Company has received approval from the TSX Venture Exchange (“TSXV“) to list the Warrants issued pursuant to the Offering, and the Warrants are expected to be listed and posted for trading on the TSXV under the ticker symbol “BABY.WT” effective on or about October 8, 2020.

Concurrent with the Offering, the Company issued 2,224,111 Units on a private placement basis, for additional gross proceeds of approximately CAD$5 million (the “Private Placement“). New H2 Limited (“New H2“), a wholly owned subsidiary of Health and Happiness (H&H) International Holdings Ltd, a Hong Kong Stock Exchange company (HK:1112), subscribed for CAD$4,000,000 worth of Units in the Private Placement pursuant to a previously disclosed investor rights agreement dated March 2, 2020 between the Company and New H2.

In total, the Company received gross proceeds of approximately CAD$25.7 million from the closing of the Offering and Private Placement.

The Offering was conducted on a bought deal basis by Canaccord Genuity Corp. and Haywood ‎Securities Inc. (collectively, the “Underwriters“). On closing, the Company issued to the Underwriters an aggregate ‎of 597,920 broker warrants (the “Broker Warrants“), each Broker Warrant entitling the holder to ‎purchase one Share at the price of CAD$2.25 per Share until October 6, 2022.‎

The Units issued pursuant to the Offering were offered by way of a short form prospectus filed in all provinces of Canada except Quebec and elsewhere on a private placement basis. The Company intends to use the net proceeds of the Offering and the Private Placement for marketing, distribution, inventory and general corporate purposes.

All securities issued in connection with the Private Placement are subject to a four month hold period pursuant to the policies of the TSX Venture Exchange and applicable securities laws.

The securities offered have not been, nor will they be, registered under the U.S Securities Act of 1933 (the “U.S. Securities Act“) or any ‎state securities laws, and may not be offered or sold in the United States or to, or for the account or ‎benefit of, any person in the United States or to U.S. Persons (as such term is defined in Regulation S ‎under the U.S. Securities Act) absent registration or an applicable exemption from the registration ‎requirements. This news release will not constitute an offer to sell or the solicitation of an offer to buy ‎nor will there be any sale of the securities in any state in which such offer, solicitation or sale would be ‎unlawful.‎

MI 61-101

New H2’s subscription for Units in the Private Placement constitutes a “related party transaction” within the meaning of TSXV Policy 5.9 and Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The transaction is exempt from the formal valuation requirements of MI 61-101 pursuant to section 5.5(a) and the minority shareholder approval requirements of MI 61-101 pursuant to section 5.7(1)(a) as the fair market value of the related party’s subscription will not be more than 25% of the Company’s market capitalization. The Company will be filing a material change report in respect of the related party transaction on SEDAR less than 21 days prior to the closing of the transaction due to the fact that the Company wished to close the transaction as soon as possible.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed on the TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For additional information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements relating to the trading date of the Warrants and the intended use of the net proceeds of ‎the Offering and the Private Placement. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Else Nutrition Holdings

Else Nutrition Holdings Inc. $BABY.ca to Webcast Live at VirtualInvestorConfences October 8th $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:18 AM on Monday, October 5th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

VANCOUVER, BC / October 5, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition today announced that [Hamutal Yitzhak], [CEO], will present at VirtualInvestorConferences.com on October 8th.

DATE: Thursday, October 8th

TIME: 4:00 PM ET

LINK: https://bit.ly/3bLR2RF

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

Recent Company Highlights

  1. Recent CAD $ 25M financing and use of proceeds
  2. Recent Amazon and website launch.
  3. Current US distribution agreements and updated plans for retail rollout.
  4. H&H Global Group, company’s largest investor increased their stake in the last round of financing, and the new territories distribution and expansion plans.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

Virtual Investor Conferences

John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
[email protected]

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Else Nutrition $BABY.ca Launches World’s First Globally Patented, Plant-Based Toddler Nutrition Formula on #Amazon.com $AMZN $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:09 AM on Thursday, September 24th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Amazon to begin online sales of Else Soy free Plant-Based Toddler Nutrition in the U.S.
  • Expanding into the world’s largest online retailer as consumers continue to eat more meals at home and increasingly rely on grocery delivery services, during the COVID-19 pandemic
  • Amazon saw online grocery sales triple year-over-year during the second quarter of 2020, as more customers continue to get their groceries delivered rather than going to a physical store
  • Selling direct to consumers through online channels, is a major pillar of Else’s global go-to-market strategy
  • Furthermore, the Company’s Amazon store will provide a convenient alternative for parents who prefer shopping online.

VANCOUVER, BC / September 24, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), is pleased to announce that its novel, first of its kind plant-based soy free Complete & clean label Nutrition for Toddlers is now available for U.S customers via Amazon.com.

Else is expanding into the world’s largest online retailer as consumers continue to eat more meals at home and increasingly rely on grocery delivery services, during the COVID-19 pandemic. Amazon saw online grocery sales triple year-over-year during the second quarter of 2020, as more customers continue to get their groceries delivered rather than going to a physical store.

Selling direct to consumers through online channels, is a major pillar of Else’s global go-to-market strategy. Furthermore, the Company’s Amazon store will provide a convenient alternative for parents who prefer shopping online.

In addition to its own e-store and the new the Amazon.com store, the Company is aggressively pursuing new channels to bring its novel products to natural food and grocery store aisles and store shelves across the United States. Grocers are eager to satisfy consumer’s growing demand for natural, clean, non-dairy and healthy alternative product offerings in the Company’s product category. This is further amplified given the massive growth and demand they are currently experiencing as a result of stay at home orders and restaurant closures.

As a result of both a consumer demand – plant-based products continue to significantly outpace overall food sales in the U.S., fueling a significant growth opportunity for retailers.

“We’re thrilled to offer Else Nutrition’s products US nation wide on Amazon.com,” said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else. “With the launch of our plant-based Toddler complete nutrition, we’ve been getting many requests from customers who want to purchase our product on Amazon.com. This is a tremendous convenience and accessibility boost using the world’s largest e-commerce platform – as we continue our singular focus to bring novel, plant-based, clean nutrition to families,” she added.

Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available on Amazon.com as both single (for US$36) and 4-pack (for US$136).

Canadian consumers can order Else’s products at www.elsenutrition.com.

To visit Else’s Amazon please see: https://www.amazon.com/dp/B08FM4NRMR/ref=cm_sw_r_wa_api_fab_ZBGAFb01N25NV

Else is pleased to announce that as of September 14, 2020, it retained Winning Media LLC (“Winning Media“) for digital marketing and advertising services. Winning Media will be engaged on a month to month term and will be compensated a total of USD$75,000 for its current scope of services. Neither Winning Media nor Else currently own securities in each other. The engagement is subject to approval from the TSX Venture Exchange.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

Media Contact:

Covet Consumer Business Unit
Gianna Totaro
[email protected]
P: 1-301-875-6574

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Else Nutrition Holdings

CLIENT FEATURE: Else Nutrition $BABY.ca The Award Winning, Plant-Based Nutrition Company For Small Cap Investors $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 5:54 PM on Thursday, September 17th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

(TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL)

A Game Changer In Plant-Based Nutrition

Highlights

  • $CAD 18M bought deal financing + $CAD 6M private placement
  • US distribution agreement signed
  • Full-scale marketing campaign launched
  • Backed by A Billion Dollar Global Nutrition Company;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • USDA Organic Certification and multiple other key certifications.
  • Partnership with celebrity author, podcast host and parenting expert, Hilaria Baldwin

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children
  • 7 Years of  R&D
  • Launched 1st Commercial Product Into US Market
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Right To Maintain 11.15% Ownership Through Future Financings

Watch Out Alec Baldwin, Hilaria’s Got a New Love 😉

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

Hub On AGORACOM / Corporate Profile

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

Else Nutrition $BABY.ca Announces an Increase to Previously Announced Bought Deal Public Offering – $18M CAD Gross Proceeds + Up to $6M CAD Via Private Placement $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 2:16 PM on Wednesday, September 16th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Underwriters have agreed to purchase, on a bought deal basis, an aggregate of 8,000,000 units of the Company at a price of C$2.25 per Unit for aggregate gross proceeds to the Company of C$18 million
  • In addition to the Offering, the Company is increasing the size of its previously announced non-brokered private placement to up to 2,666,666 Units at the Offering Price for gross proceeds to the Company of up to C$6 million

VANCOUVER, BC, Sept. 16, 2020 – Else Nutrition Holdings (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”), is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (the “Underwriters”) pursuant to which the Underwriters have agreed to increase the size of its previously announced bought deal financing. The Underwriters have agreed to purchase, on a bought deal basis, an aggregate of 8,000,000 units (the “Units”) of the Company at a price of C$2.25 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of C$18 million (the “Offering”).

Each Unit shall consist of one common share (each a “Common Share”) and one-half of one common share purchase warrant of the Company (each whole common share purchase warrant, a “Warrant”). Each Warrant shall be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 24 months from closing of the Offering at an exercise price of C$3.25 per Warrant, subject to adjustment in certain events.

The Company has granted the Underwriters an option (the “Over-Allotment Option”) to purchase up to an additional 1,200,000 Units at the Offering Price, which Over-Allotment Option will be exercisable at any time and from time-to-time, for a period of 30 days following the Closing Date (as defined below), which would result in additional gross proceeds of C$2.7 million. The Over-Allotment Option is exercisable to acquire Units, Common Shares and/or Warrants (or any combination thereof) at the discretion of the Underwriters.

The Units will be offered by way of a short form prospectus to be filed in all provinces of Canada except Quebec and elsewhere on a private placement basis. The Offering is expected to close on October 6, 2020 (the “Closing Date”) and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the TSX Venture Exchange and the applicable securities regulatory authorities.

In addition to the Offering, the Company is increasing the size of its previously announced non-brokered private placement to up to 2,666,666 Units at the Offering Price for gross proceeds to the Company of up to C$6 million (the “Concurrent Private Placement”).  No commission or finder’s fee is payable to the Underwriters in connection with the Concurrent Private Placement.

The Company intends to use the proceeds of the Offering for marketing, distribution, inventory and general corporate purposes.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. The securities offered have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed on the TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements relating to the timing and ‎completion of the Offering, the satisfaction and timing of the receipt of required stock exchange ‎approvals and other conditions to closing of the Offering and the intended use of the net proceeds of ‎the Offering. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE Else Nutrition Holdings Inc.

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director, ELSE Nutrition Holdings Inc., E: [email protected], P: +972(0)3-6445095; Mr. Sokhie Puar, Director, ELSE Nutrition Holdings Inc., E: [email protected], P: 604-603-7787Copyright CNW Group 2020

Else Nutrition $BABY.ca Announces $10 Million Bought Deal and Concurrent up to $5 million Private Placement $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 4:14 PM on Tuesday, September 15th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, an aggregate of 4,445,000 units of the Company at a price of $2.25 per Unit for aggregate gross proceeds to the Company of approximately C$10 million
  • In addition to the Offering, the Company is proposing to undertake a non-brokered private placement of up to 2,222,222 Units at the Offering Price for gross proceeds to the Company of up to C$5 million

VANCOUVER, BC, Sept. 15, 2020 – Else Nutrition Holdings (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”), is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, an aggregate of 4,445,000 units (the “Units”) of the Company at a price of $2.25 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of approximately C$10 million (the “Offering”). 

Each Unit shall consist of one common share (each a “Common Share”) and one-half of one common share purchase warrant of the Company (each whole common share purchase warrant, a “Warrant”). Each Warrant shall be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 24 months from closing of the Offering at an exercise price of C$3.25 per Warrant, subject to adjustment in certain events. 

The Company has granted the Underwriters an option (the “Over-Allotment Option”) to purchase up to an additional 666,750 Units at the Offering Price, which Over-Allotment Option will be exercisable at any time and from time-to-time, for a period of 30 days following the Closing Date (as defined below), which would result in additional gross proceeds of approximately $1.5 million. The Over-Allotment Option is exercisable to acquire Units, Common Shares and/or Warrants (or any combination thereof) at the discretion of the Underwriters. 

The Units will be offered by way of a short form prospectus to be filed in all provinces of Canada except Quebec and elsewhere on a private placement basis. The Offering is expected to close on October 6, 2020 (the “Closing Date”) and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the TSX Venture Exchange and the applicable securities regulatory authorities.

In addition to the Offering, the Company is proposing to undertake a non-brokered private placement of up to 2,222,222 Units at the Offering Price for gross proceeds to the Company of up to C$5 million (the “Concurrent Private Placement”).  No commission or finder’s fee is payable to the Underwriters in connection with the Concurrent Private Placement.

The Company intends to use the proceeds of the Offering for marketing, distribution, inventory and general corporate purposes.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. The securities offered have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed on the TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements relating to the timing and ‎completion of the Offering, the satisfaction and timing of the receipt of required stock exchange ‎approvals and other conditions to closing of the Offering and the intended use of the net proceeds of ‎the Offering. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE Else Nutrition Holdings Inc.

Else Nutrition $BABY.ca and KeHE Distributors Sign Distribution Agreement to Bring Novel Plant-Based Toddler Nutrition Product to US Retailers $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:18 AM on Monday, September 14th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Officially signed a distribution agreement with KeHE Distributors
  • KeHE has nearly 70 years of experience servicing store owners and today has a network of over 16 distribution centers across North America
  • KeHE is one of the largest and most well regarded national fresh, natural and organic and specialty food distributors in North America
  • This agreement will open distribution of Else’s ground breaking plant based toddler nutrition products to thousands of store shelves in the United States

VANCOUVER, BC / September 14, 2020 / Else Nutrition Holdings (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company”), is pleased to announce that as part of its efforts to make its novel, plant-based toddler nutrition products accessible to families across North America, that it has officially signed a distribution agreement with KeHE Distributors. KeHE has nearly 70 years of experience servicing store owners and today has a network of over 16 distribution centers across North America. KeHE is one of the largest and most well regarded national fresh, natural and organic and specialty food distributors in North America. This agreement will open distribution of Else’s ground breaking plant based toddler nutrition products to thousands of store shelves in the United States. Distribution of Else’s first product, Plant-based Complete Nutrition for Toddlers, will commence in October 2020 from KeHE’s California Oregon distribution centers.

“From the early days of our journey our singular focus has been to deliver to families a healthy, nutritious alternative to dairy based formulas for babies and toddlers. Distribution through KeHE means that our products will soon be available to customers at their favorite stores across America. This marks a major step in distribution, and we are thrilled to be working with a real leader in natural foods distribution. KeHE and Else align perfectly, as we both share a passion for healthy eating and sustainable,” said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else.

With over 16 distribution centers, and 5,500 employees across North America, KeHE serves over 30,000 retail outlets. An employee-owned, B Corp-certified company, KeHE supplies natural food stores, supermarket chains, independent grocery stores and other specialty retailers across North America through its distribution centers.

Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available for order on Else’s e-store at elsenutrition.com.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed on the TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For additional information, contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for starting retail rollout with KeHE distributors in Q4, or the results of such retail rollout. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Plant-based diets shine when looking at the gut health SPONSOR – Else Nutrition $BABY.ca $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 3:55 PM on Thursday, September 10th, 2020

SPONSOR: Else Nutrition Holdings Inc. (TSX-V: BABY) The award winning, plant-based nutrition company for small cap investors. The company has a $7,000,000 cash balance for US product launch with International agreements coming soon. Learn More.

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Plant-based diets shine when looking at the gut health

  • Microbiome of the gut is created at birth, the study notes, but continues to develop throughout infancy and is significantly affected throughout childhood by diet
  • There is a large shift in the composition of the gut as infants are weaned and begin consuming solid foods, with the makeup of the gut resembling that of adults by about age 3 years

By: Rachael Zimlich, RN, BSN

A recent study investigating how foods impact gut health in children points to plant-based proteins, fresh fruits and vegetables, and grains as key to a diverse and healthy microbiome.

There has been a wealth of evidence collected on how important the gut microbiome is for health maintenance, but little research has been done on how diet habits are related to gut health in prepubescent children. A recent study took a closer look.

The study,1 published in the Journal of the Academy of Nutrition and Dietetics, reveals that gut health in young children and pre-pubescent teenagers is both dynamic and diverse, and is particularly responsive to certain food groups.

“The gut microbiome remains dynamic for children past 3 years of age and responds to dietary differences,” says lead author Dena Herman, PhD, MPH, RD, professor at California State University, Northridge and director of the MCH Nutrition Leadership Training Program at the UCLA Fielding School of Public Health. “This represents an opportunity to learn healthy habits early in life so that they can be sustained over the life course to maximize health.”

The health of the gut plays a vital role in maintaining health and supporting immune functions, the study notes. The microbiome is impacted by a number of factors, with individualized diets being one of the most important determinants of a diverse gut environment.

The microbiome of the gut is created at birth, the study notes, but continues to develop throughout infancy and is significantly affected throughout childhood by diet. There is a large shift in the composition of the gut as infants are weaned and begin consuming solid foods, with the makeup of the gut resembling that of adults by about age 3 years. Little research has been done on the makeup of the childhood gut between 3 years of age and the adolescent years, the study notes, but dietary patterns have been associated with significant differences in the guts of children in the age range of 4 to 8 years. As diets have shifted more toward a Western diet, heavily featuring highly processed foods and high-fat animal products, more and more diseases have been attributed to an imbalance in the microbial composition of the gut, the study reveals.

To examine how diet influenced gut health in the study group, researchers asked parents to collect fecal samples and quantitative 24-hour diet recalls, investigating each 3 times, each time about 6 days apart. The team examined how diet impacted gut health by splitting children into groups based on the types of food they consumed. Protein consumption—both animal- and plant-based—was the only food group that was associated with gut diversity. Total grain and vegetable consumption, on the other hand, heavily influenced the community makeup of the microbiome, the study notes. The research team noted some surprise here, in that yogurt was the only animal-derived food that was associated with the membership and structure of the microbiome. Instead, proteins were more closely linked to higher levels of diversity in the types of microorganisms found in the gut, the study states. The most abundant microorganisms found in the study groups were Bacteroides and Prevotella. The first was tied to Western diets, and the latter to fiber-rich diets.

Adequate diversity in the microbiome samples was noted, with results appropriate for the cohort’s age group. The research team found that older children in the study group had more diversity in their gut microbiomes, and that gender had no impact on the results. There were a number of trends noted with different food groups, such as lower diversity with a high non- whole-food grain consumption, and abundance of certain bacteria groups with higher consumption of fruit and fiber.

Overall, the study revealed that fresh fruits and vegetable consumption led to increased variation in the structure of the microbiome—with citrus, melon, and berries contributing most to gut diversity. Whole and non-whole grains were key to maintaining gut health, immune health, and glucose regulation, Herman stated. B-vitamins also played a big role in gut health, contributing to microbiome structure and composition, she says.

The 2- to 9-year-old group studied in this report is significant, because this represents a time when diets are becoming more diverse, and children begin to explore and become more independent in their eating habits. The study highlights the need to make this time count, the study notes, with guidance from adults on healthy eating habits to help promote good health and disease prevention in adulthood.

“Early and middle childhood may represent a crucial window when the gut microbiome might still be amenable to lasting manipulations through diet,” the study reveals.

The study emphasizes the importance of diet in the development of a healthy microbiome during the childhood years, with non-whole-grain foods enriched with vitamins and minerals being perhaps one of the largest contributors to gut health in this pilot sample.

“There are many benefits of a healthy gut for children. First and foremost, is an enhanced immune response. Young children are often more susceptible to upper respiratory tract infections and ear infections, especially if they are in childcare and as they enter school,” Herman explains. “By maintaining a diverse diet, children have a better chance of maximizing the healthy bacteria that can support immune health.”

The benefits of a healthy gut don’t end with physical health, she adds. Mental health effects were not the focus of the study, Herman says, but there has been prior research drawing a strong connection between gut health and brain health.

“For children this could translate into better focus in school allowing them to reach their academic potential. Unlike other studies, this study showed that children past 3 years of age are still able to change the structure and membership of their microbiome through the foods that they eat,” she says. “This is exciting and helps us extend the findings from studies in adults to children. The benefits described for children are similar for adults. However, as we age we have increased risk for inflammation, which can lead to higher rates of chronic diseases including cancers. That is why it is important to start healthy habits as early in life as possible.”

Although the study was small, it was more detailed than most previously conducted research examining gut health in children, she says. It highlights the benefits of plant-based diets, which Herman says she hopes will convince parents and clinicians to make changes—both for their children and themselves.

“I would hope that the results we have shared provide further support for the promotion of a plant-based diet—not only for young children, but also for adults. Parents are role models for their children’s eating habits and this study shows that we can actively engage in making positive changes to our gut health and overall health starting at a young age,” Herman says. “As a pediatric dietitian myself, I would hope that we could work together with the medical community, particularly pediatricians, to promote healthy habits including healthful eating habits and regular exercise through anticipatory guidance at all well-child visits. With the high rates of obesity in the United States, having children consume foods that support reduced risk for obesity may translate into lower risks for obesity-related diseases in adulthood such as cardiovascular disease and diabetes. Starting this practice as early as possible will ensure the most benefit for these children and generations to come.”

Reference

1. Herman D, Rhoades N, Mercado J, Argueta P, Lopez U, Flores G. Dietary habits of 2- to 9-year-old american children are associated with gut microbiome composition. J Acad Nutr Diet. 2020;120(4):517-534. doi:10.1016/j.jand.2019.07.024

Source: https://www.contemporarypediatrics.com/view/plant-based-diets-shine-when-looking-at-the-gut-microbiome